Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Vanaja Reddy Middekadi"'
Autor:
Ramakrishna, Nirogi, Abdul Rasheed, Mohammed, Anil Karbhari, Shinde, Shankar Reddy, Gagginapally, Durga Malleshwari, Kancharla, Srinivasa Rao, Ravella, Narsimha, Bogaraju, Vanaja Reddy, Middekadi, Ramkumar, Subramanian, Raghava Choudary, Palacharla, Vijay, Benade, Nageswararao, Muddana, Renny, Abraham, Rajesh Babu, Medapati, Jagadeesh Babu, Thentu, Venkat Reddy, Mekala, Surendra, Petlu, Bujji Babu, Lingavarapu, Sivasekhar, Yarra, Narendra, Kagita, Vinod Kumar, Goyal, Santosh Kumar, Pandey, Venkat, Jasti
Publikováno v:
Journal of medicinal chemistry. 64(15)
A series of oxadiazole derivatives were synthesized and evaluated as 5-hydroxytryptamine-4 receptor (5-HT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0658b7f6a1d5f4d39f7637a5b2805752
https://pubmed.ncbi.nlm.nih.gov/34251799
https://pubmed.ncbi.nlm.nih.gov/34251799
Autor:
Pooja Singh, Nageswararao Muddana, Ramakrishna Nirogi, Narsimha Bogaraju, Abdul Rasheed Mohammed, Srinivasa Rao Ravella, Raghava Choudary Palacharla, Ramkumar Subramanian, Shankar Reddy Gagginapally, Shinde Anil Karbhari, Vanaja Reddy Middekadi, Durga Malleshwari Kancharla, Pradeep Jayarajan, Vijay Benade, Sumit Raosaheb Birangal
Publikováno v:
Journal of Medicinal Chemistry. 61:4993-5008
Alzheimer’s disease (AD) is a neurodegenerative disorder that has a higher prevalence and incidence in people older than 60 years. The need for improved AD therapies is unmet as the current therapies are symptomatic with modest efficacy. Partial ag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::99c12a66cd15dcfd5d91660e6cac491a
https://doi.org/10.1021/acs.jmedchem.8b00457
https://doi.org/10.1021/acs.jmedchem.8b00457